Dana–Farber Harvard Cancer Center - PDFSEARCH.IO - Document Search Engine

Dana–Farber Harvard Cancer Center
Results: 91

#	Item
51	Dana-Farber/Harvard Cancer Center Note-To-File Add to Reading List Source URL: www.dfhcc.harvard.edu - Date: 2011-08-31 17:02:21
52	DANA-FARBER / HARVARD CANCER CENTER STANDARD OPERATING PROCEDURES FOR HUMAN SUBJECT RESEARCH TITLE: Preparation for Site Close Out SOP #: RCL-100 (formerly PM-416) Add to Reading List Source URL: www.dfhcc.harvard.edu Language: English - Date: 2014-02-20 09:19:59 Pharmacology Pharmaceutical industry Design of experiments Institutional review board Case report form Clinical trial Protocol Investigational New Drug Investigational Device Exemption Research Clinical research Pharmaceutical sciences
53	INSTITUTE FOR INTERNATIONAL LAW & HUMAN RIGHTS OVERVIEW OF RESEARCH INSTITUTES AUGUSTPREPARED BY Add to Reading List Source URL: www.iilhr.org Language: English - Date: 2015-01-18 19:05:14 Cancer research Oncology War on Cancer National Cancer Institute National Research Council Office of Cancer Complementary and Alternative Medicine Dana–Farber/Harvard Cancer Center Medicine Cancer organizations National Institutes of Health
54	DANA-FARBER / HARVARD CANCER CENTER Add to Reading List Source URL: www.dfhcc.harvard.edu Language: English - Date: 2012-07-02 10:40:51 Pharmaceutical industry Pharmacology Clinical Data Management Case report form Clinical trial Investigational Device Exemption Dana–Farber Cancer Institute Regulatory compliance Quality assurance Research Clinical research Pharmaceutical sciences
55	DANA-FARBER / HARVARD CANCER CENTER STANDARD OPERATING PROCEDURES FOR HUMAN SUBJECT RESEARCH TITLE: SOP #: Page: 1 of Effective Date: Add to Reading List Source URL: www.dfhcc.harvard.edu Language: English - Date: 2012-09-17 08:36:39 Health Pharmacology Drug safety Food and Drug Administration Title 21 of the Code of Federal Regulations Clinical investigator Institutional review board Investigational New Drug Investigational Device Exemption Medicine Clinical research Research
56	2008 Dana Farber Harvard Cancer Center, Renal Cancer Program – Kidney Cancer Association – Survivor Conference Agenda 8:30 – Breakfast Add to Reading List Source URL: www.dfhcc.harvard.edu Language: English - Date: 2011-08-31 17:02:36 Organofluorides Kidney cancer Pyridines Orphan drugs Pyrroles Sunitinib Temsirolimus Axitinib Sorafenib Medicine Chemistry Organic chemistry
57	DANA-FARBER / HARVARD CANCER CENTER Add to Reading List Source URL: www.dfhcc.harvard.edu Language: English - Date: 2012-09-18 08:06:27 Medicine Pharmaceutical industry Pharmacology Standard operating procedure Clinical trial Clinical investigator Dana–Farber Cancer Institute Procedure Regulatory requirement Research Clinical research Science
58	CIRB Operations Office c/o: The EMMES Corporation 401 N. Washington St. Suite 700 Rockville, MDTel: Toll Free) Fax: Add to Reading List Source URL: www.dfhcc.harvard.edu Language: English - Date: 2014-10-16 14:02:04 Cancer organizations Clinical research Design of experiments Pharmacology Medical ethics Dana–Farber Cancer Institute Dana–Farber/Harvard Cancer Center Clinical trial Farber Medicine Health Science
59	DFCI Intranet : News Page 1 of 3 Home Add to Reading List Source URL: www.dfhcc.harvard.edu Language: English - Date: 2012-11-29 17:00:55 Cancer organizations Medicine Dana–Farber Cancer Institute Dana–Farber/Harvard Cancer Center Farber Health Biotechnology Harvard Medical School Laboratories
60	DANA-FARBER / HARVARD CANCER CENTER Add to Reading List Source URL: www.dfhcc.harvard.edu Language: English - Date: 2012-09-17 17:21:02 Medical ethics Applied ethics Drug safety Autonomy Pharmaceutical industry Institutional review board Informed consent Investigational Device Exemption Investigational New Drug Ethics Clinical research Research

UPDATE